The WACC of Viaderma Inc (VDRM) is 5.1%.
| Range | Selected | |
| Cost of equity | 48.50% - 143.50% | 96.00% |
| Tax rate | 24.70% - 27.10% | 25.90% |
| Cost of debt | 4.90% - 4.90% | 4.90% |
| WACC | 4.4% - 5.8% | 5.1% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 9.71 | 24.75 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 48.50% | 143.50% |
| Tax rate | 24.70% | 27.10% |
| Debt/Equity ratio | 62.25 | 62.25 |
| Cost of debt | 4.90% | 4.90% |
| After-tax WACC | 4.4% | 5.8% |
| Selected WACC | 5.1% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for VDRM:
cost_of_equity (96.00%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (9.71) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.